NCT01531348View on ClinicalTrials.gov

Intravitreal Injection of MSCs in Retinitis Pigmentosa

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
Retinitis Pigmentosa
Interventions
OTHER

BM-MSC

Bone marrow-derived mesenchymal stem cells 1 million cells in balanced salt solution 100 microlitres will be injected into the vitreous cavity.

Trial Locations (1)

10700

Siriraj Hospital Mahidol University, Bangkoknoi

All Listed Sponsors
collaborator

Ministry of Health, Thailand

OTHER_GOV

lead

Mahidol University

OTHER

NCT01531348 - Intravitreal Injection of MSCs in Retinitis Pigmentosa | Biotech Hunter | Biotech Hunter